Content area

|
|

Intrakraniel hypertension sekundært til systemisk lupus erythematosus

Forfatter(e)

Hafed Amin Saidane, Aydin Gozalov & Vlasta Vukovic Cvetkovic

Neurologisk Klinik, Rigshospitalet

Ugeskr Læger 2021;183:V10200782

Reference: 
Ugeskr Læger 2021;183:V10200782
Intracranial hypertension secondary to systemic lupus erythematosus

Hafed Amin Saidane, Aydin Gozalov & Vlasta Vukovic Cvetkovic

Ugeskr Læger 2021;183:V10200782

Systemic lupus erythematosus (SLE) is a diagnostically challenging autoimmune multisystem disease with intracranial hypertension as a rare initial clinical manifestation. This is a case report of a 27-year-old woman with a prior history of psychogenic non-epileptic attacks, intracranial hypertension, headache, visual impairment, papilloedema, and a BMI of 24 kg/m2. Upon acetazolamide treatment for intracranial hypertension and before the diagnosis of SLE was reached, the patient developed respiratory distress and metabolic acidosis, due to underlying SLE glomerulonephritis.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Kamaran Shorsh | 24/09
2 kommentarer
af Julius Vindbjerg Nissen | 24/09
4 kommentarer
af Carsten Anker Edmund | 24/09
26 kommentarer
af Helle Lone Jensen | 23/09
1 Kommentar
af Martin Gottliebsen | 21/09
2 kommentarer
af Bente Ulla Rasmusson | 20/09
1 Kommentar
af Carsten Reidies Bjarkam | 18/09
1 Kommentar